Wilmington Rexford

Wilmington Rexford, Inc. was a strategic venture development company that operated in the early 2000s, primarily focused on acquiring and managing a portfolio of diverse businesses. In 2004, the company executed a significant pivot into the life sciences sector by acquiring a controlling interest in Zhejiang University Pharmaceutical, Co., Ltd. (Zheda Pharmacy), a prominent pharmaceutical manufacturer in China. Following this acquisition, the company reorganized and changed its name to China Pharmaceuticals Corporation to better reflect its new core business. As part of the transition, it spun off its technology-focused subsidiary, E-Trend Networks, and appointed new leadership to oversee its expansion in the Chinese pharmaceutical market. The company was historically traded on the OTCBB under the ticker symbols WREX and WREXE.